Large-scale drug screen in patient-derived IDHmut glioma stem cells identifies several FDA-approved antineoplastic agents

Authors :: Dao Trong, P
Jungwirth, G
Yu, T
Pusch, S
Herold-Mende, C
Warta, R
Unterberg, AW
Source :: 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie; 20200621-20200624; sine loco [digital]; DOCV086 /20200626/
Publication Year :: 2020
Publisher :: German Medical Science GMS Publishing House, 2020.
Abstract: Objective: The discovery of the Isocitrate Dehydrogenase (IDH) mutation in glioma has led to a paradigm shift on how we see glioma biology. While it is clear that IDH mutated (IDHmut) and wildtype (IDHwt) tumors have to be viewed as separate entities, the underlying biological differences are still [for full text, please go to the a.m. URL]<br />71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Language :: English
Database :: OpenAIRE
Journal :: 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie; 20200621-20200624; sine loco [digital]; DOCV086 /20200626/
Accession number :: edsair.doi.dedup.....c7b151dd7917f5a3b3d6b303ec1c44ac
Full Text :: https://doi.org/10.3205/20dgnc089

Full Text Access

Tools